{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:53:03Z","timestamp":1783529583257,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clim.2021.108765","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T13:07:11Z","timestamp":1622639231000},"page":"108765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus"],"prefix":"10.1016","volume":"229","author":[{"given":"Panagiotis A.","family":"Ntouros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos I.","family":"Vlachogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianos","family":"Nezos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Tektonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis L.","family":"Souliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2021.108765_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14760584.2019.1675519","article-title":"Preexisting influenza specific immunity and vaccine effectiveness","volume":"18","author":"Jang","year":"2019","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.clim.2021.108765_bb0015","doi-asserted-by":"crossref","first-page":"108409","DOI":"10.1016\/j.clim.2020.108409","article-title":"Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic","volume":"215","author":"Gasmi","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.clim.2021.108765_bb0025","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0030","doi-asserted-by":"crossref","first-page":"101422","DOI":"10.1016\/j.smim.2020.101422","article-title":"The immunology of SARS-CoV-2 infections and vaccines","volume":"50","author":"Grigoryan","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0035","doi-asserted-by":"crossref","first-page":"108634","DOI":"10.1016\/j.clim.2020.108634","article-title":"COVID-19: a review of therapeutic strategies and vaccine candidates","volume":"222","author":"Izda","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2012.12.008","article-title":"Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines","volume":"38","author":"Obermoser","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108765_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9194","article-title":"Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets","volume":"9","author":"Athale","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.coviro.2011.07.002","article-title":"Innate and adaptive immune responses to viral infection and vaccination","volume":"1","author":"Aoshi","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.clim.2021.108765_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0891-5849(96)00131-1","article-title":"Oxidative stress during viral infection: a review","volume":"21","author":"Schwarz","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.micinf.2017.08.008","article-title":"The role of oxidative stress in influenza virus infection","volume":"19","author":"Liu","year":"2017","journal-title":"Microbes Infect."},{"key":"10.1016\/j.clim.2021.108765_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/ijms21010055","article-title":"DNA damage response and oxidative stress in systemic autoimmunity","volume":"21","author":"Souliotis","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.clim.2021.108765_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2012.07.018","article-title":"Autoinflammation and autoimmunity: bridging the divide","volume":"12","author":"Doria","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2021.108765_bb0075","article-title":"Systemic Lupus Erythematosus","volume":"12","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2021.108765_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0095","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0961203314565413","article-title":"Increased DNA double-strand breaks and enhanced apoptosis in patients with lupus nephritis","volume":"24","author":"Souliotis","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2021.108765_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13075-016-1081-3","article-title":"Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus","volume":"18","author":"Souliotis","year":"2016","journal-title":"Arthrit. Res Ther."},{"key":"10.1016\/j.clim.2021.108765_bb0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.immuni.2015.01.012","article-title":"DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity","volume":"42","author":"H\u00e4rtlova","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108765_bb0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.celrep.2015.03.041","article-title":"Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells","volume":"11","author":"Shen","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2021.108765_bb0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2021.108765_bb0120","doi-asserted-by":"crossref","first-page":"102329","DOI":"10.1016\/j.jaut.2019.102329","article-title":"Increased adenosine-to-inosine RNA editing in rheumatoid arthritis","volume":"106","author":"Vlachogiannis","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2021.108765_bb0125","doi-asserted-by":"crossref","first-page":"582401","DOI":"10.3389\/fimmu.2020.582401","article-title":"Association between DNA damage response, fibrosis and type I interferon signature in systemic sclerosis","volume":"11","author":"Vlachogiannis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2021.108765_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2016.10.015","article-title":"Increased frequency of the PTPN22W* variant in primary Sjogren\u2019s Syndrome: association with low type I IFN scores","volume":"173","author":"Vlachogiannis","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clim.2019.03.009","article-title":"DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis","volume":"203","author":"Souliotis","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0145","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1158\/0008-5472.CAN-08-3489","article-title":"Association between transcriptional activity, local chromatin structure, and the efficiencies of both subpathways of nucleotide excision repair of melphalan adducts","volume":"69","author":"Episkopou","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2021.108765_bb0150","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.clim.2021.108765_bb0155","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.011","article-title":"The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where","volume":"154","author":"Pateras","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.clim.2021.108765_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI78001","article-title":"Defective removal of ribonucleotides from DNA promotes systemic autoimmunity","volume":"125","author":"G\u00fcnther","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2021.108765_bb0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","article-title":"Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing","volume":"39","author":"Gehrke","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108765_bb0175","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2021.108765_bb0180","first-page":"2516","article-title":"DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice","volume":"118","author":"Meira","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2021.108765_bb0185","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1161\/CIRCULATIONAHA.105.535435","article-title":"Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals","volume":"112","author":"Vlachopoulos","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2021.108765_bb0190","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active Systemic Lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0200","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.clim.2021.108765_bb0205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through Type I Interferon and Interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108765_bb0215","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/icb.2012.10","article-title":"Role of type I interferons in the activation of autoreactive B cells","volume":"90","author":"Kiefer","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.clim.2021.108765_bb0220","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.20092695","article-title":"Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response","volume":"207","author":"Swanson","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2021.108765_bb0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T cell responses by type I interferons","volume":"15","author":"Crouse","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/14760584.7.3.373","article-title":"Type I interferons as vaccine adjuvants against infectious diseases and cancer","volume":"7","author":"Bracci","year":"2008","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.clim.2021.108765_bb0235","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/4\/2\/026001","article-title":"Effect of influenza vaccination on oxidative stress products in breath","volume":"4","author":"Phillips","year":"2010","journal-title":"J. Breath Res."},{"key":"10.1016\/j.clim.2021.108765_bb0240","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehm247","article-title":"Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects","volume":"28","author":"Vlachopoulos","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clim.2021.108765_bb0245","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cardiores.2004.06.020","article-title":"Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress","volume":"64","author":"Clapp","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.clim.2021.108765_bb0250","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2021.108765_bb0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2011.04301.x","article-title":"Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I","volume":"9","author":"Passam","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2021.108765_bb0260","doi-asserted-by":"crossref","first-page":"33834","DOI":"10.1074\/jbc.M110.165175","article-title":"Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies","volume":"285","author":"Otaki","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2021.108765_bb0265","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/art.27442","article-title":"Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity","volume":"62","author":"Wang","year":"2010","journal-title":"Arthrit. Rheumat."},{"key":"10.1016\/j.clim.2021.108765_bb0270","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthrit. Rheumat."},{"key":"10.1016\/j.clim.2021.108765_bb0275","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0280","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","article-title":"Interleukin-17 and systemic lupus erythematosus: current concepts","volume":"157","author":"Nalbandian","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.143.1.103","article-title":"T cell receptor alpha\/beta expressing double-negative (CD4-\/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis","volume":"143","author":"Shivakumar","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-220272","article-title":"Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort","author":"Geisen","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2021.108765_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-220289","article-title":"Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases","author":"Boyarsky","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2021.108765_bb0300","doi-asserted-by":"crossref","first-page":"E4782","DOI":"10.1073\/pnas.1703683114","article-title":"Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases","volume":"114","author":"McNally","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2021.108765_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015423","article-title":"The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus","volume":"5","author":"Yoon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2021.108765_bb0310","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.immuni.2013.08.039","article-title":"Anthracyclines induce DNA damage response-mediated protection against severe sepsis","volume":"39","author":"Figueiredo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2021.108765_bb0315","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/clim.2001.5023","article-title":"Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28lo T cells in patients with Systemic Lupus Erythematosus","volume":"99","author":"Honda","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108765_bb0320","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrc2440","article-title":"Living on a break: cellular senescence as a DNA-damage response","volume":"8","author":"d\u2019Adda di Fagagna","year":"2008","journal-title":"Nat. Rev. Cancer"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:35Z","timestamp":1761494675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":64,"alternative-id":["S1521661621001029"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108765","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108765"}}